Cilgavimab Uses, Dosage, Side Effects and more
Cilgavimab is under investigation in clinical trial NCT04625725 (Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.).
| Trade Name | Cilgavimab |
| Generic | Cilgavimab |
| Cilgavimab Other Names | Cilgavimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
